Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation

被引:11
|
作者
Perez, Ariadna [1 ]
Montoro, Juan [2 ]
Hernani, Rafael [1 ]
Lorenzo, Ignacio [2 ]
Carlos Hernandez-Boluda, Juan [1 ,3 ]
Gimenez, Estela [4 ]
Dolores Gomez, Maria [5 ]
Balaguer-Rosello, Aitana [2 ]
Gonzalez-Barbera, Eva [5 ]
Guerreiro, Manuel [2 ]
Aguilar, Cristobal [2 ]
Navarro, David [3 ,4 ]
Solano, Carlos [1 ,3 ]
Sanz, Jaime [2 ,3 ,6 ]
Luis Pinana, Jose [2 ,6 ]
机构
[1] Fdn INCLIVA, Hosp Clin Univ, Dept Hematol, Valencia, Spain
[2] Hosp Univ & Politecn la Fe, Dept Hematol, Valencia, Spain
[3] Univ Valencia, Sch Med, Dept Med, Valencia, Spain
[4] Hosp Clin Univ, Microbiol Serv, Valencia, Spain
[5] Univ Valencia, Sch Med, Dept Microbiol, Valencia, Spain
[6] Inst Carlos III, CIBERONC, Madrid, Spain
关键词
allogeneic stem cell; community acquired respiratory virus; immunodeficiency scoring index; rhinovirus; trasplantation; HUMAN RHINOVIRUS INFECTIONS; INFLUENZA INFECTIONS; PARAINFLUENZA VIRUS; SYNCYTIAL VIRUS; RECIPIENTS; OUTCOMES; ADULTS; TRACT;
D O I
10.1111/tid.13301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Enterovirus/rhinoviruses (EvRh) are the most common cause of respiratory virus infections in recipients of allogeneic stem cell transplantation (allo-HSCT). Objective We sought to analyze the value of the immunodeficiency scoring index (ISI) in predicting lower respiratory tract disease (LRTD) progression and mortality in a prospective cohort of consecutive adult (>16 years) allo-HSCT recipients with EvRh infection from December 1 2013 to December 1 2019 at two Spanish transplant centers. Results We included 234 allo-HSCT recipients with 383 EvRh episodes. Out of 383 EvRh episodes, 98 (25%) had LRTD. Multivariate logistic regression analysis identified three independent factors associated with LRTD progression: Ig G < 400 mg/dL, community-acquired respiratory virus (CARV) co-infection and high-risk ISI. Inclusion of Ig G levels and CARV co-infection in the ISI improved its performance by significantly increasing the area under the receiver operator characteristic curve (AUROC) from 0.643 to 0.734 (P = .03). Likewise, the two conditions identified by multivariate analyses as associated with higher probability of mortality were high-risk ISI and EvRh infection within 6 months after transplant. Conclusions Our findings confirm the value of high-risk ISI in predicting both probability of EvRh LRTD and 3-month overall mortality. We also demonstrate that the original ISI could be adapted to other CARV types by including additional variables to improve its performance.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Quantitative assessment of hematopoietic chimerism after allogeneic nonmyeloalblative stem cell transplantation.
    Chen, Bao-An
    Xiong, Hui-Xia
    Ding, Jia-Hua
    Gao, Chong
    Sun, Yun-Yu
    Wang, Jun
    Cheng, Jian
    Zhao, Gang
    Chen, Ning-Na
    Fei, Fei
    BLOOD, 2006, 108 (11) : 400B - 400B
  • [42] Palivizumab treatment of respiratory syncytial virus infection after allogeneic stem cell transplantation
    Sicre, F.
    Robin, M.
    de Latour, R. Peffault
    Porcher, R.
    Scieux, C.
    Ferry, C.
    Rocha, V.
    Boudjedir, K.
    Devergie, A.
    Bergeron, A.
    Gluckman, A.
    Azoulay, E.
    Lapalu, J.
    Socie, G.
    Ribaud, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 78 - 78
  • [43] Heart failure after allogeneic hematopoietic stem cell transplantation
    Mo, Xiao-Dong
    Xu, Lan-Ping
    Liu, Dai-Hong
    Zhang, Xiao-Hui
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Wang, Yu
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Zhao, Ting
    Yan, Chen-Hua
    Sun, Yu-Qian
    Liu, Kai-Yan
    Huang, Xiao-Jun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (06) : 2502 - 2506
  • [44] MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Comak, Elif
    Dogan, Cagla Serpil
    Gokceoglu, Arife Uslu
    Yesilipek, Akif
    Koyun, Mustafa
    Akman, Sema
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1686 - 1686
  • [45] Bronchial Disorders After Allogeneic Hematopoietic Stem Cell Transplantation
    Bergeron, A.
    Godet, C.
    Chevret, S.
    Lorillon, G.
    de Latour, R. Peffault
    Robin, M.
    Ribaud, P.
    Socie, G.
    Tazi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [46] Diabetes Mellitus after Allogeneic Hematopoietic Stem Cell Transplantation
    Wedrychowicz, Anna
    Ciechanowska, Marta
    Stelmach, Malgorzata
    Starzyk, Jerzy
    HORMONE RESEARCH IN PAEDIATRICS, 2013, 79 (01): : 44 - 50
  • [47] Bullous pemphigoid after allogeneic hematopoietic stem cell transplantation
    Kato, Keisuke
    Koike, Kazutoshi
    Kobayashi, Chie
    Iijima, Shigeruko
    Hashimoto, Takashi
    Tsuchida, Masahiro
    PEDIATRICS INTERNATIONAL, 2015, 57 (03) : 480 - 483
  • [48] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Yingxue Lu
    Xiaojing Ma
    Jie Pan
    Rongqiang Ma
    Yujie Jiang
    Lipids in Health and Disease, 21
  • [49] Graft failure after allogeneic hematopoietic stem cell transplantation
    Ozdemir, Zehra Narli
    Bozdag, Sinem Civriz
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (02) : 163 - 167
  • [50] ABO antibodies after allogeneic hematopoietic stem cell transplantation
    Stussi, G
    Huggel, K
    Schanz, U
    Halter, J
    Passweg, J
    Gratwohl, A
    Seebach, JD
    BONE MARROW TRANSPLANTATION, 2003, 31 : S114 - S114